Abstract 4357831: Sacubitril/valsartan in resistant hypertension: Longitudinal improvements in blood pressure control accompanied by increasing adverse event rates

Authors

Abdalhakim Shubietah, Advocate Health - MidwestFollow
Mohamed Elgendy
Qutaiba Qafisheh
et al

Recommended Citation

Shubietah A, Elgendy M, Qafisheh Q, et al. Abstract 4357831: Sacubitril/Valsartan in Resistant Hypertension: Longitudinal Improvements in Blood Pressure Control Accompanied by Increasing Adverse Event Rates. Circulation. 2025/11/04 2025;152(Suppl_3):A4357831-A4357831. doi:10.1161/circ.152.suppl_3.4357831

Affiliations

Advocate Illinois Masonic Med Ctr

Type

Abstract